FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934


For the month of May 2012

Commission File Number: 001-15152


SYNGENTA AG
(Translation of registrant’s name into English)

Schwarzwaldallee 215
4058 Basel
Switzerland
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
X
 
Form 40-F
 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes
   
No
X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes
   
No
X

Indicate by check mark whether by furnishing the information contained in this Form, the Registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes
   
No
X

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
 
 


 
 
 
 
 
Re: 
SYNGENTA AG
Disclosure:
Syngenta settles atrazine litigation in the USA

Herewith we furnish a press release related to Syngenta AG. The full text of the press release is the following:

# # #

 
 

 
 
Syngenta International AG
 
Media Office
CH-4002 Basel
Switzerland
Tel:      +41 61 323 23 23
Fax:     +41 61 323 24 24
 
www.syngenta.com
Media contact:
 
Ann Bryan         +1 336 632 2486
Paul Minehart  +1 202 737 8913
USA
 
Daniel Braxton
Switzerland      +41 61 323 2323
 
Analyst/Investor contact:
 
Jennifer Gough
Switzerland +41 61 323 5059
USA              +1 202 737 6521
 
 

 
Basel, Switzerland, May 25, 2012

Syngenta settles atrazine litigation in the USA

As announced today, Syngenta and attorneys for several community water systems have agreed to settle litigation related to the herbicide atrazine in order to end the business uncertainty and expense of protracted legal proceedings. The proposed settlement agreement which requires court approval was filed with the United States District Court for the Southern District of Illinois on May 24, 2012.

Under the terms of the agreement, Syngenta expressly denied liability and the plaintiffs acknowledged that they are not aware of any new scientific studies relating to atrazine.

The total cost of the settlement for Syngenta is $105 million, which will be charged to the income statement in 2012. The charge is partly covered by provisions and the impact on earnings will be approximately $0.5 per share.

Syngenta will continue to market atrazine as part of its comprehensive corn herbicide portfolio enabling US growers to achieve optimal weed control.


Syngenta is one of the world's leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com





Cautionary Statement Regarding Forward-Looking Statements
 
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

Syngenta – May 25, 2012 / Page 1 of 1
 
 

 
 

   
SYNGENTA AG
 
       
       
Date:
May 25, 2012
 
By:
/s/ Sandra Bürli-Borner  
       
Name:
Sandra Bürli-Borner
 
       
Title:
Legal Counsel
 
             
             
             
             
             
             
             
             
     
By:
/s/ Brigitte Benz  
       
Name:
Brigitte Benz
 
         
Head Shareholder Services